The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 6
  • 1
    Naidoo, Kiren Lee
    Company Director born in June 1985
    Individual (3 offsprings)
    Officer
    2021-01-20 ~ now
    OF - director → CIF 0
  • 2
    Selamoglu, Mehmet Levent
    Company Director born in September 1959
    Individual (3 offsprings)
    Officer
    2021-01-20 ~ now
    OF - director → CIF 0
  • 3
    Kaye, Steven Jonathan
    Director born in September 1965
    Individual (8 offsprings)
    Officer
    2021-02-02 ~ now
    OF - director → CIF 0
  • 4
    Samson, Marvin Stanley
    Director born in June 1941
    Individual (1 offspring)
    Officer
    2021-02-02 ~ now
    OF - director → CIF 0
  • 5
    Mr Joseph Ensink
    Born in April 1964
    Individual (30 offsprings)
    Person with significant control
    2024-07-25 ~ now
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
  • 6
    Kemp House, 160 City Road, London, United Kingdom
    Corporate (3 parents, 1 offspring)
    Equity (Company account)
    775,326 GBP2024-04-30
    Person with significant control
    2021-02-02 ~ now
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
Ceased 2
  • 1
    Mr Kiren Lee Naidoo
    Born in June 1985
    Individual (3 offsprings)
    Person with significant control
    2021-01-20 ~ 2024-03-05
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
  • 2
    Mr Joseph Ensink
    Born in April 1964
    Individual (30 offsprings)
    Person with significant control
    2021-03-18 ~ 2024-03-05
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
parent relation
Company in focus

FRONTIER BIOPHARMA LIMITED

Previous name
DRINA HOLDINGS LIMITED - 2023-09-07
Standard Industrial Classification
64202 - Activities Of Production Holding Companies
Brief company account
Audit Fees/Expenses
26,000 GBP2023-01-01 ~ 2023-12-31
26,000 GBP2022-02-01 ~ 2022-12-31
Tax Expense/Credit at Applicable Tax Rate
-519,577 GBP2023-01-01 ~ 2023-12-31
-411,422 GBP2022-02-01 ~ 2022-12-31
Intangible Assets - Accumulated Amortisation & Impairment
1,827,657 GBP2023-12-31
1,067,870 GBP2022-12-31
Intangible Assets - Increase From Amortisation Charge for Year
759,787 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
5,672,311 GBP2023-12-31
3,877,007 GBP2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
1,877,124 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Other Disposals/Decrease in Depreciation & Impairment
-81,820 GBP2023-01-01 ~ 2023-12-31
Other Taxation & Social Security Payable
Current
58,146 GBP2023-12-31
89,640 GBP2022-12-31
Cash and Cash Equivalents
25,553 GBP2023-12-31
322 GBP2022-12-31
0 GBP2022-01-31
Total Borrowings
Current
445,559 GBP2023-12-31
0 GBP2022-12-31
Non-current
3,823,126 GBP2023-12-31
3,823,126 GBP2022-12-31
Equity
Called up share capital
1,731,526 GBP2023-12-31
1,731,526 GBP2022-12-31
1,731,526 GBP2022-01-31
Retained earnings (accumulated losses)
-1,095,454 GBP2023-12-31
-667,920 GBP2022-12-31
Equity
636,072 GBP2023-12-31
1,063,606 GBP2022-12-31
-301,660 GBP2022-01-31
Profit/Loss
Retained earnings (accumulated losses)
-427,534 GBP2023-01-01 ~ 2023-12-31
-366,260 GBP2022-02-01 ~ 2022-12-31
Wages/Salaries
104,108 GBP2023-01-01 ~ 2023-12-31
0 GBP2022-02-01 ~ 2022-12-31
Pension & Other Post-employment Benefit Costs/Other Pension Costs
5,205 GBP2023-01-01 ~ 2023-12-31
0 GBP2022-02-01 ~ 2022-12-31
Staff Costs/Employee Benefits Expense
122,738 GBP2023-01-01 ~ 2023-12-31
0 GBP2022-02-01 ~ 2022-12-31
Trade Creditors/Trade Payables
Current
20,337 GBP2023-12-31
0 GBP2022-12-31
Non-current
0 GBP2023-12-31
0 GBP2022-12-31
Accrued Liabilities
Current
75,500 GBP2023-12-31
41,500 GBP2022-12-31
Other Interest Receivable/Similar Income (Finance Income)
-4,576 GBP2023-01-01 ~ 2023-12-31
0 GBP2022-02-01 ~ 2022-12-31
  • FRONTIER BIOPHARMA LIMITED
    Info
    DRINA HOLDINGS LIMITED - 2023-09-07
    Registered number 13146422
    C/o Flb Accountants Llp 1010 Eskdale Road, Winnersh Triangle, Wokingham RG41 5TS
    Private Limited Company incorporated on 2021-01-20 (4 years 4 months). The company status is Active.
    The last date of confirmation statement was made at 2025-01-19
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.